BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36188586)

  • 1. WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis.
    Zhang RS; Li ZK; Liu J; Deng YT; Jiang Y
    Front Pharmacol; 2022; 13():976117. PubMed ID: 36188586
    [No Abstract]   [Full Text] [Related]  

  • 2. Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation.
    Zhang Q; Liu Q; Zheng S; Liu T; Yang L; Han X; Lu X
    J Cancer; 2021; 12(16):4830-4840. PubMed ID: 34234853
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose transporter‑1 inhibition overcomes imatinib resistance in gastrointestinal stromal tumor cells.
    Shima T; Taniguchi K; Tokumaru Y; Inomata Y; Arima J; Lee SW; Takabe K; Yoshida K; Uchiyama K
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34738628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
    Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
    World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of pro-oxidative acting vanicosides and GLUT1 inhibitor (WZB117) exerts a synergistic cytotoxic effect against melanoma cells.
    Nawrot-Hadzik I; Matkowski A; Fast M; Choromańska A
    Fitoterapia; 2023 Dec; 171():105702. PubMed ID: 37848084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apatinib Inhibits Angiogenesis in Intrahepatic Cholangiocarcinoma by Regulating the Vascular Endothelial Growth Factor Receptor-2/Signal Transducer and Activator of Transcription Factor 3/Hypoxia Inducible Factor 1 Subunit Alpha Signaling Axis.
    Huang MP; Gu SZ; Huang B; Li GW; Xiong ZP; Tang T; Zeng SN
    Pharmacology; 2021; 106(9-10):509-519. PubMed ID: 34412054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib weakens proliferation, migration, invasion, and angiogenesis of thyroid cancer cells through downregulating pyruvate kinase M2.
    Yang X; Li W; Han X; Wang J; Dai J; Ye X; Meng M
    Sci Rep; 2024 Jan; 14(1):879. PubMed ID: 38195651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib inhibits glycolysis by suppressing the VEGFR2/AKT1/SOX5/GLUT4 signaling pathway in ovarian cancer cells.
    Chen L; Cheng X; Tu W; Qi Z; Li H; Liu F; Yang Y; Zhang Z; Wang Z
    Cell Oncol (Dordr); 2019 Oct; 42(5):679-690. PubMed ID: 31325096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKM2 is involved in neuropathic pain by regulating ERK and STAT3 activation in rat spinal cord.
    Wang B; Liu S; Fan B; Xu X; Chen Y; Lu R; Xu Z; Liu X
    J Headache Pain; 2018 Jan; 19(1):7. PubMed ID: 29349661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells.
    Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH
    J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 12. The Combined Metabolically Oriented Effect of Fucoidan from the Brown Alga
    Malyarenko OS; Usoltseva RV; Silchenko AS; Zueva AO; Ermakova SP
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer.
    Xie C; Zhou X; Liang C; Li X; Ge M; Chen Y; Yin J; Zhu J; Zhong C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):266. PubMed ID: 34429133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia.
    Deng M; Zha J; Jiang Z; Jia X; Shi Y; Li P; Chen XL; Fang Z; Du Z; Xu B
    J Transl Med; 2018 Feb; 16(1):47. PubMed ID: 29490645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of pyruvate kinase M2 promotes liver regeneration via activation of signal transducer and activator of transcription 3.
    Hu K; Xu J; Fan K; Zhou D; Li L; Tang L; Peng X; Zhang L; Wang Y
    Life Sci; 2020 Jun; 250():117561. PubMed ID: 32198052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WZB117 Decorated Metformin-Carboxymethyl Chitosan Nanoparticles for Targeting Breast Cancer Metabolism.
    De A; Wadhwani A; Sauraj ; Roychowdhury P; Kang JH; Ko YT; Kuppusamy G
    Polymers (Basel); 2023 Feb; 15(4):. PubMed ID: 36850263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma.
    Cui L; Yan L; Guan X; Dong B; Zhao M; Lv A; Liu D; Wang Z; Liu F; Wu J; Tian X; Hao C
    Front Oncol; 2021; 11():739139. PubMed ID: 34868934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment.
    Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C
    Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-rich plasma improves chronic inflammatory pain by inhibiting PKM2-mediated aerobic glycolysis in astrocytes.
    Wei X; Jin XH; Meng XW; Hua J; Ji FH; Wang LN; Yang JP
    Ann Transl Med; 2020 Nov; 8(21):1456. PubMed ID: 33313201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Inhibition of Ornithine Decarboxylase 1 and Pyruvate Kinase M2 Exerts Synergistic Effects Against Hepatocellular Carcinoma Cells.
    Zeng Z; Lan J; Lei S; Yang Y; He Z; Xue Y; Chen T
    Onco Targets Ther; 2020; 13():11697-11709. PubMed ID: 33244237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.